Reset Map20-25 Uhlandstraße Berlin, Berlin, 10623 GermanyYashraj Biotechnology Ltd. (YBL) is a human-relevant global NAM-based solutions provider. It delivers functionally validated, translationally relevant cell models that de-risk preclinical drug discovery. Every model is built from ethically sourced, consented human cells. Manufacturing runs out of a state-of-art GMP-compliant facility, certified to ISO 9001:2015, ISO 13485:2016, ISO 27001, and ISO 45001. The core portfolio includes YBLiCardioTM, CiPA-validated beating human iPSC-derived cardiomyocytes - the first in the world to report a plating efficiency of ~80% across multiple batches. Peer-reviewed testing across all 28 CiPA compounds aligned with the HESI benchmark study, with improved sensitivity on select compounds including chlorpromazine. The portfolio also includes other hiPSC-derivatives including YBLiHepatoTM, and primary human skin cell systems — NHEKTM, NHEMTM, and NHDFTM— each supported by matched expansion media. YBL offerings go beyond these catalogue products. Custom assay biology and screening support safety, efficacy, and mechanism-of-action studies. The toolkit spans high-throughput and high-content screening, 2D/3D co-culture, and complex in vitro models with genuine biological relevance. Applications cover cardiotoxicity, DILI, OECD skin-based assays and therapeutic screening. A core team of PhD scientists leads the work supported by quality, operations and commercial experts. YBL supports biopharma sponsors, CROs, and academic institutions worldwide — with an India-based operation built for fast turnaround into its global sponsor base.
Porte La Paz San Diego, CA, 92122 United StatesYashraj Biotechnology Ltd. (YBL) is a human-relevant global NAM-based solutions provider. It delivers functionally validated, translationally relevant cell models that de-risk preclinical drug discovery. Every model is built from ethically sourced, consented human cells. Manufacturing runs out of a state-of-art GMP-compliant facility, certified to ISO 9001:2015, ISO 13485:2016, ISO 27001, and ISO 45001. The core portfolio includes YBLiCardioTM, CiPA-validated beating human iPSC-derived cardiomyocytes - the first in the world to report a plating efficiency of ~80% across multiple batches. Peer-reviewed testing across all 28 CiPA compounds aligned with the HESI benchmark study, with improved sensitivity on select compounds including chlorpromazine. The portfolio also includes other hiPSC-derivatives including YBLiHepatoTM, and primary human skin cell systems — NHEKTM, NHEMTM, and NHDFTM— each supported by matched expansion media. YBL offerings go beyond these catalogue products. Custom assay biology and screening support safety, efficacy, and mechanism-of-action studies. The toolkit spans high-throughput and high-content screening, 2D/3D co-culture, and complex in vitro models with genuine biological relevance. Applications cover cardiotoxicity, DILI, OECD skin-based assays and therapeutic screening. A core team of PhD scientists leads the work supported by quality, operations and commercial experts. YBL supports biopharma sponsors, CROs, and academic institutions worldwide — with an India-based operation built for fast turnaround into its global sponsor base.
MIDC Turbhe Navi Mumbai, MH, 400705 IndiaYashraj Biotechnology Ltd. (YBL) is a human-relevant global NAM-based solutions provider. It delivers functionally validated, translationally relevant cell models that de-risk preclinical drug discovery. Every model is built from ethically sourced, consented human cells. Manufacturing runs out of a state-of-art GMP-compliant facility, certified to ISO 9001:2015, ISO 13485:2016, ISO 27001, and ISO 45001. The core portfolio includes YBLiCardioTM, CiPA-validated beating human iPSC-derived cardiomyocytes - the first in the world to report a plating efficiency of ~80% across multiple batches. Peer-reviewed testing across all 28 CiPA compounds aligned with the HESI benchmark study, with improved sensitivity on select compounds including chlorpromazine. The portfolio also includes other hiPSC-derivatives including YBLiHepatoTM, and primary human skin cell systems — NHEKTM, NHEMTM, and NHDFTM— each supported by matched expansion media. YBL offerings go beyond these catalogue products. Custom assay biology and screening support safety, efficacy, and mechanism-of-action studies. The toolkit spans high-throughput and high-content screening, 2D/3D co-culture, and complex in vitro models with genuine biological relevance. Applications cover cardiotoxicity, DILI, OECD skin-based assays and therapeutic screening. A core team of PhD scientists leads the work supported by quality, operations and commercial experts. YBL supports biopharma sponsors, CROs, and academic institutions worldwide — with an India-based operation built for fast turnaround into its global sponsor base.
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.